Millikan RC - Search Results

1

Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.

Brennan DJ, Laursen H, O'Connor DP, Borgquist S, Uhlen M, Gallagher WM, Pontén F, Millikan RC, Rydén L, Jirström K. Brennan DJ, et al. Among authors: millikan rc. Breast Cancer Res. 2011 Jan 31;13(1):R12. doi: 10.1186/bcr2820. Breast Cancer Res. 2011. PMID: 21281480 Free PMC article.

2

The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.

Brennan DJ, O'Connor DP, Laursen H, McGee SF, McCarthy S, Zagozdzon R, Rexhepaj E, Culhane AC, Martin FM, Duffy MJ, Landberg G, Ryden L, Hewitt SM, Kuhar MJ, Bernards R, Millikan RC, Crown JP, Jirström K, Gallagher WM. Brennan DJ, et al. Among authors: millikan rc. Oncogene. 2012 Jul 26;31(30):3483-94. doi: 10.1038/onc.2011.519. Epub 2011 Dec 5. Oncogene. 2012. PMID: 22139072 Free PMC article.

3

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL. Brennan DJ, et al. Among authors: millikan rc. Clin Cancer Res. 2006 Nov 1;12(21):6421-31. doi: 10.1158/1078-0432.CCR-06-0480. Clin Cancer Res. 2006. PMID: 17085655 Clinical Trial.

4

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM. O'Brien SL, et al. Among authors: millikan rc. Int J Cancer. 2007 Apr 1;120(7):1434-43. doi: 10.1002/ijc.22413. Int J Cancer. 2007. PMID: 17205517 Free PMC article.

5

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.

Brennan DJ, Rexhepaj E, O'Brien SL, McSherry E, O'Connor DP, Fagan A, Culhane AC, Higgins DG, Jirstrom K, Millikan RC, Landberg G, Duffy MJ, Hewitt SM, Gallagher WM. Brennan DJ, et al. Among authors: millikan rc. Clin Cancer Res. 2008 May 1;14(9):2681-9. doi: 10.1158/1078-0432.CCR-07-1760. Clin Cancer Res. 2008. PMID: 18451232 Free PMC article.

6

Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.

Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J, Jirstrom K, Landberg G, Martin F, Duffy MJ, Gallagher WM. Lanigan F, et al. Among authors: millikan rc. Int J Cancer. 2009 May 1;124(9):2088-97. doi: 10.1002/ijc.24159. Int J Cancer. 2009. PMID: 19142967

7

Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis.

Ryan D, Rafferty M, Hegarty S, O'Leary P, Faller W, Gremel G, Bergqvist M, Agnarsdottir M, Strömberg S, Kampf C, Pontén F, Millikan RC, Dervan PA, Gallagher WM. Ryan D, et al. Among authors: millikan rc. Pigment Cell Melanoma Res. 2010 Aug;23(4):542-53. doi: 10.1111/j.1755-148X.2010.00720.x. Epub 2010 Apr 30. Pigment Cell Melanoma Res. 2010. PMID: 20465595

8

Molecular subtyping of breast cancer: opportunities for new therapeutic approaches.

Mullan PB, Millikan RC. Mullan PB, et al. Among authors: millikan rc. Cell Mol Life Sci. 2007 Dec;64(24):3219-32. doi: 10.1007/s00018-007-7389-z. Cell Mol Life Sci. 2007. PMID: 17957336 Free PMC article. Review.

9

Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.

Conway K, Edmiston SN, Cui L, Drouin SS, Pang J, He M, Tse CK, Geradts J, Dressler L, Liu ET, Millikan R, Newman B. Conway K, et al. Cancer Res. 2002 Apr 1;62(7):1987-95. Cancer Res. 2002. PMID: 11929815

10

HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.

Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang WY, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L. Millikan R, et al. Breast Cancer Res Treat. 2003 Jun;79(3):355-64. doi: 10.1023/a:1024068525763. Breast Cancer Res Treat. 2003. PMID: 12846420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters